Arena Pharmaceuticals, Inc.

Press Releases



All Releases

View Summary Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results
Aug 1, 2013
PDF 24.2 KB Add to Briefcase
View Summary Arena Pharmaceuticals' BELVIQ® (lorcaserin HCl) CIV Nominated for 2013 Prix Galien USA Award
Jul 25, 2013
PDF 15.9 KB Add to Briefcase
View Summary Arena Pharmaceuticals and CY Biotech Enter into Marketing and Supply Agreement for BELVIQ® (lorcaserin HCl) in Taiwan
Jul 25, 2013
PDF 13.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, August 1
Jul 24, 2013
PDF 10.6 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces BELVIQ™ (lorcaserin HCl) New Drug Submission in Canada
Jun 26, 2013
PDF 64.1 KB Add to Briefcase
View Summary BELVIQ® (lorcaserin HCl) CIV Data to be Presented at the American Diabetes Association's 73rd Scientific Sessions
Jun 20, 2013
PDF 18.2 KB Add to Briefcase
View Summary BELVIQ® (lorcaserin HCl) CIV Data to be Presented at ENDO 2013
Jun 14, 2013
PDF 18.2 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the 2013 Wells Fargo Securities Healthcare Conference
Jun 14, 2013
PDF 10.4 KB Add to Briefcase
View Summary Arena Pharmaceuticals Reports on Launch of BELVIQ® (lorcaserin HCl) CIV for Chronic Weight Management in Adults who are Overweight with a Comorbidity or Obese
Jun 7, 2013
PDF 18.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
May 24, 2013
PDF 10.7 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 10, 2013
PDF 10.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals Provides Update on Upcoming US Launch of BELVIQ® (lorcaserin HCl) for Chronic Weight Management
May 7, 2013
PDF 16.8 KB Add to Briefcase
View Summary Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
May 2, 2013
PDF 23.2 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2
Apr 26, 2013
PDF 10.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases
Apr 5, 2013
PDF 11.3 KB Add to Briefcase
View Summary Arena Pharmaceuticals Announces Eisai's Submission of BELVIQ® (lorcaserin HCl) Marketing Authorization Application in Mexico
Apr 1, 2013
PDF 17.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
Mar 4, 2013
PDF 25.2 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
Feb 27, 2013
PDF 10.1 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Monday, March 4
Feb 25, 2013
PDF 10.5 KB Add to Briefcase
View Summary Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
Feb 6, 2013
PDF 10.4 KB Add to Briefcase
Showing 41-60 of 462 Page: 1 2 3 4 5 6 7 ... 24  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase